Why this seasoned money manager sees real upside for this innovative B2B tech startup. on 10/26/2021. Learn More

Sector Expert: Charles Wiseman

BriaCell Therapeutics Corp.

Image: Charles Wiseman

Charles Wiseman, M.D., founder and CMO of BriaCell, pioneered the use of chemotherapy and has 45 years' experience in oncology. He has served as director of the immunotherapy lab at St. Vincent Medical Center in Los Angeles. At the University of Texas MD Anderson Hospital and Tumor Institute, he served as chief of the breast cancer basic research lab and as assistant professor in the department of molecular carcinogenesis and virology. He was acting chief of the division of oncology at White Memorial Medical Center in Los Angeles.

Recent Interviews

Breakthrough Potential: BriaCell Therapeutics Takes Its Cancer Vaccine to the Next Level (9/30/15)

Immuno-oncology has the potential to not only transform medicine, but also to become a multibillion-dollar market for a drug developer with the right team and the right compound. In this interview with The Life Sciences Report, BriaCell Therapeutics Corp. executives Joseph Wagner, Charles Wiseman and Saeid Babaei describe their company's new therapeutic, which has generated stunning results in early trials, making "breakthrough" designation by the FDA a realistic possibility.

Due to permission requirements, not all quotes are shown.